Phylex BioSciences
Pre-clinicalWe are developing the first AI-derived mRNA nanoparticle vaccines with advanced deep learning AI models. Our mRNA vaccines directly encoding for highly immunogenic nanoparticles provide a flexible platform directly applicable to zoonotic viruses that constitute a rising threat worldwide.
Founded
2016
Focus
RNA & Gene TherapyVaccines
About
We are developing the first AI-derived mRNA nanoparticle vaccines with advanced deep learning AI models. Our mRNA vaccines directly encoding for highly immunogenic nanoparticles provide a flexible platform directly applicable to zoonotic viruses that constitute a rising threat worldwide.
Company Info
TypePrivate
Founded2016
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile